Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Janne Grøndahl ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   5.2% 3.3% 3.9% 3.1% 2.3% 3.6% 12.1% 11.8%   Credit score (0-100)   44 56 50 55 65 52 20 20   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 -0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   2,119 2,081 1,885 1,870 2,008 1,830 0.0 0.0   EBITDA   -229 228 115 198 407 197 0.0 0.0   EBIT   -431 26.1 -86.9 -2.3 266 62.2 0.0 0.0   Pre-tax profit (PTP)   -474.9 -24.7 -121.4 -38.0 210.1 13.1 0.0 0.0   Net earnings   -370.6 -19.6 -94.8 -29.7 163.8 9.8 0.0 0.0   Pre-tax profit without non-rec. items   -475 -24.7 -121 -38.0 210 13.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   217 145 73.2 27.7 16.4 11.5 0.0 0.0   Shareholders equity total   -262 -282 -377 -406 -242 -233 -283 -283   Interest-bearing liabilities   1,234 869 891 779 589 446 662 662   Balance sheet total (assets)   1,593 1,456 1,321 1,041 894 693 379 379   Net Debt   1,228 838 877 773 587 445 662 662     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   2,119 2,081 1,885 1,870 2,008 1,830 0.0 0.0   Gross profit growth   -26.8% -1.8% -9.4% -0.8% 7.4% -8.8% -100.0% 0.0%   Employees   6 5 4 4 4 4 0 0   Employee growth %   0.0% -16.7% -20.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,593 1,456 1,321 1,041 894 693 379 379   Balance sheet change%   -17.9% -8.6% -9.3% -21.2% -14.1% -22.5% -45.2% 0.0%   Added value   -229.4 228.0 115.0 197.9 466.0 197.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -404 -404 -404 -376 -282 -270 -11 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -1.0 1.0 -1.0 -2.0 1.0 2.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -20.4% 1.3% -4.6% -0.1% 13.2% 3.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -22.5% 1.6% -5.0% -0.1% 20.7% 6.0% 0.0% 0.0%   ROI %   -28.1% 2.1% -6.6% -0.2% 26.8% 8.2% 0.0% 0.0%   ROE %   -43.6% -1.3% -6.8% -2.5% 16.9% 1.2% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   -14.3% -16.4% -22.6% -28.5% -21.6% -25.6% -42.7% -42.7%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -535.1% 367.5% 762.3% 390.8% 144.1% 225.7% 0.0% 0.0%   Gearing %   -470.6% -308.5% -236.8% -191.8% -242.9% -191.9% -234.2% -234.2%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   4.0% 5.2% 3.9% 4.3% 8.3% 9.5% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.2 0.5 0.6 0.4 0.3 0.3 0.0 0.0   Current Ratio   0.4 0.7 0.7 0.7 0.7 0.6 0.0 0.0   Cash and cash equivalent   5.7 31.3 14.9 5.8 2.1 1.4 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -470.5 -183.4 -172.0 -167.4 -139.0 -169.0 -330.9 -330.9   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -38 46 29 49 117 49 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -38 46 29 49 102 49 0 0   EBIT / employee   -72 5 -22 -1 66 16 0 0   Net earnings / employee   -62 -4 -24 -7 41 2 0 0